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Abstract
The impact of simulated storage conditions (accelerated ageing) for the chemical purity 
of innovative ultra-light textile implants (knitted) designed for use in urogynaecology and 
general surgery (procedures in the treatment of female incontinence, in hernia treatment 
and vagina plastic surgery) was estimated. The chemical purity of the knitted implants de-
signed: untreated and with low-temperature plasma surface treatment in the presence of the 
fluoroorganic compounds was estimated. The acceptability of the risk related to the impact 
of storage conditions on the chemical purity of the implant products was simulated. The 
examination was based on Standard PN-EN ISO 10993-18:2008: “Biological evaluation 
of medical devices - Part 18: Chemical characterisation of materials” and was assessed in 
accordance with Polish and European standards.
Key words: ultra-light knitted implants, accelerated ageing, chemical purity, leachable 
substances.
developed surface, which promotes the 
growing through of connective tissue 
and provides better fastening of the im-
plant, particularly in suture-less surgery. 
Moreover in the scope of the investiga-
tion, low–temperature plasma treatment 
of the surface of knitted implants was ap-
plied, which was expected to reduce the 
risk of complications related to the ad-
hesion of the implant to internal organs, 
particularly in low-invasive surgery. The 
main quality demands that are set before 
the implant materials are as follows: a 
fast growing-through of the tissue, quick 
healing, biocompatibility, and lack of ir-
ritation of human tissue.
The reaction of the human organism to a 
foreign body is distinctly reduced when-
ever ultra-light, non-resorbable poly-
propylene monofilament meshes (trade 
name OPTOMESHTM, Optilene® Mesh 
LP) are used in hernia repair. The mono-
filament structure minimises the risk of 
bacterial infection.
The present investigation is aimed at a 
possible reduction of the irritating ac-
tion of the polymeric material introduced 
to the organism by applying ultra-light 
polypropylene monofilament knitwear 
of possibly low surface density and very 
fine spatial structure, which has the effect 
of introducing a minimised amount of 
synthetic material to the patient’s organ-
ism.
Chemical purity and its stability in medi-
cal devices is a key issue concerning bio-
compatibility. It is assumed that materials 
tissue defects in the abdominal and ingui-
nal surgery. It enables a tissue tension-
free operation, thus largely reducing pain 
and shortening hospitalisation. 
Knitted fabrics find ever wider applica-
tion in medicine by improving patients’ 
health, thanks to features like high tenac-
ity, low density, lack of water imbibition 
and good healing properties.
Research made so far in the designing 
of the medical devices from innovative, 
polypropylene, ultra-light knitted fabrics 
for use in urogynaecology (procedures 
in the treatment of female incontinence 
and vagina plastic surgery) and general 
surgery (hernia treatment) has met the 
expectations of medicine and patients 
themselves [4 - 12].
Non-resorbable meshes made of poly-
propylene multi -or monofilaments (class 
IIB) are designed for hernia surgery. 
They have been available world-wide 
for many years, for example in Poland 
under the trade name, OPTOMESH®PP, 
DALLOP. 
Urology polypropylene bands have 
long since been used in the surgery for 
female incontinence (market product 
DALLOP®NM, class IIB).
One of the main disadvantages of the im-
plants is a high surface density reflected 
in the high mass of the synthetic mate-
rial implanted, which may be the reason 
for a local chronic reaction. Therefore 
lighter implants with a sufficient tenac-
ity are strived for. Another aspect of 
textile implant structures is the one-side 
n Introduction
Impressive progress can be seen in mod-
ern implant surgery. Yet more discrimi-
nating quality requirements are set before 
materials to be used in implants, fostered 
by the increasing demand. The lower-
ing age of implant users is another fac-
tor calling for high quality, which results 
in novelty materials being sought, made 
according to the most advanced tech-
nologies to provide as high as possible 
connection between the implant and sub-
stituted part of the body and its function. 
This is why modern medical devices are 
the most expensive man-made materials 
[1, 2]. 
There is a wide range of medical applica-
tions for resins thanks to their different 
properties when compared to metallic 
and ceramic materials. Good forming 
ability, easy sterilisation, bio-inertness, 
non-allergenic and non-toxic action, and 
adequate physical-chemical properties 
are amongst the beneficial qualities and 
behaviour of polymers [3].
Polypropylene (PP) is an implantable 
material which has recently found wide 
use mainly in non-resorbable surgery 
meshes for the reconstruction of soft tis-
sue defects in hernia repair. The use of 
polypropylene meshes was a real break-
through in the treatment of connective 
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which under simulated conditions deliver 
chemical substances may, though not nec-
essarily, cause a local reaction of the tis-
sue into which they are implanted. Lack 
of the implant’s biocompatibility causes 
a complex, difficult- to-define reactions 
which, in the extreme, may lead to the re-
jection of the implant. This, together with 
the synergy and complexity of the phe-
nomena proceeding in the course of the 
migration of substances from the implant, 
is an obstacle in defining parameters that 
would quality- and quantity-wise limit 
the chemical substances. Characteristics 
of the chemical substance leached from 
the implant is solely a support in defin-
ing the quality base for modified and 
commercial medical devices, including 
a stability assessment of the quality and 
quantity level (assessment in accelerated 
ageing examination and real ageing). 
Knowledge of the chemical composi-
tion and, what is more important, of the 
qualitative and quantitative composition 
of the substance which migrates in the 
course of simulated clinical use does not 
permit, particularly in the case of newly 
developed or much modified medical de-
vices, to relate to biocompatibility. The 
latter is to be tested in the course of in 
vivo and in vitro examination as defined 
in ISO 10993-1. 
Ultra-light textile implants that come into 
contact with tissue and body fluids must 
satisfy specific demands set for biomate-
rials like material biocompatibility. The 
last is manifested by the fact that the ma-
terial is chemically and immunologically 
neutral and does not reveal any toxic or 
destructive action in the given environ-
ment of the organism. 
When designing implant materials, com-
plying with demands like mechanical-, 
useful- and physical-chemical properties 
is a precondition but does not guarantee 
success. Really crucial is the response of 
the cells that approach the implant’s sur-
face.
Ultra-light textile implants are 3D medi-
cal structures with a three-direction 
orientation of the polypropylene fibers 
(medical-grade monofilament - class VI 
according to American Pharmacopoeia). 
Medical grade PP features the lowest 
density amongst commercial polymers; 
it is classified as a neutral polymer, 
meaning that it contains only a minimal 
amount of auxiliary substances which are 
neither delivered to nor degrade in a bio-
logical environment. 
PP is an inert polymer without covalent 
bonds in the chain, which is why the 
surface of PP implants requires func-
tionalisation. It was in the prototypes of 
the medical devices designed that this 
was accomplished by low-temperature 
plasma surface modification in the pres-
ence of a low-molecular fluoroorganic 
compound (the fluorocarbon polymer 
layer deposited). That kind of modifi-
cation, by the depositing of a thin layer 
(25 - 50 Å), affects the quality of cell 
response, biocompatibility and hydro-
philic properties; moreover it accelerates 
the adhesion process and proliferation 
[13 - 15]. The active surface layer of the 
implant not only enables the tailoring 
of surface properties such as wettability 
and surface energy but also provides the 
chance of controlling the material degra-
dation process [16]. 
A very important aspect is the adapting of 
chemical properties including the quanti-
tative and qualitative profile of leachable 
substances, and the physical properties of 
the implant material surface. This results 
in biocompatibility and the possibility to 
stimulate tissue regeneration, which in-
creases the chances of the better accept-
ance of the implant in vivo [17].
One unavoidable part of the research is 
the assessment of the clinical risk of us-
ing polymeric materials as implants by 
analysing the mechanisms of degradation 
and assessing quantity-wise the degrada-
tion products that may be delivered in the 
course of chemical reactions, migration 
and depolymerisation.
It was also important in the investigation 
to learn the influence of storage condi-
tions of the final product designed upon 
the quantitative and qualitative profile of 
leachable substances determined in the 
testing of chemical purity. Therefore the 
method of accelerated ageing is being 
used more and more for designed medi-
cal devices to anticipate risk defined as a 
profile of potential leachable substances 
in conditions of simulated storage and 
clinical handling [18]. 
In this work, as a part of the chemical 
purity assessment of the implantable 
medical devices designed, the profile of 
leachable substances under simulated 
conditions of use (specific processing 
conditions, storage, nature and contact 
time of the product) was estimated on the 
basis of EN and ISO standards harmo-
nised with European Directives concern-
ing medical devices [19 - 23]. 
The aims of the work were as follows:
n determination of the impact of simu-
lated storage conditions on the chemi-
cal purity of the prototype knitted im-
plants designed: (a) surface-modified 
by low-temperature plasma in the 
presence of a low-molecular fluoroor-
ganic compound and (b) unmodified 
ones;
n the assessment of risk acceptability 
concerning the impact of storage con-
ditions on the chemical purity of the 
medical devices designed.
Selected prototypes of the medical de-
vices designed were subjected to acceler-
ated ageing according to a research pro-
gramme based on guidelines of Standard 
ASTM 1980F:2002. The programme was 
an extension of research published earli-




Knitted medical devices for hernioplasty 
and vaginoplasty were designed using 
polypropylene monofilament fibres with 
a diameter of 0.08 mm (linear density of 
46 dtex) with properties as described in 
[21]. 
Design of implantable medical devices
Knitted medical devices for hernioplasty 
and vaginoplasty were designed and op-
timised at the Knitting Department of the 
Lodz University of Technology based on 
the outcomes of earlier experiments [17, 
21]. 
Low- temperature plasma surface 
modification of implantable medical 
devices designed
One-side modification of the knitted 
implants prepared was made at the De-
partment of Commodity, Material Sci-
ences and Textile Metrology of the Lodz 
University of Technology by low-tem-
perature plasma treatment with fluorine 
organic derivatives (tetradecafluorohex-
ane/Fluka) using the CD 400PLC ROLL 
CASSETTE Plasma system, Europlas-
ma, Belgium. Details of the procedure of 
the modification process are described in 
[18] according to Standard [23]. 
Finishing of the implantable medical 
devices
The finishing process including the steam 
sterilisation of the knitted implants modi-
fied by low-temperature plasma with 
tetradecafluorohexane (code PF) is de-
scribed in [18] according to Standard 
[23]. The knitted implants, identical in 
structure but untreated by the low tem-
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with an integrated temperature sensor for 
measurements in pure fluids with an in-
significant amount of the deposit.
Estimation of the turbidity of the 
aqueous extracts
A method for turbidity measurements 
in aqueous extracts was prepared on 
the basis of a visual method described 
in Polish Pharmacopoeia, the VII edi-
tion. A suspension of formazin was used 
as a basic turbidity reference equal to 
4000 NTU (Nephelometric Turbidity 
Units), which is a blend of hydrazine sul-
fate and hexa(methylenetetramine) (uro-
tropin). The visual method was applied 
in instrumental turbiditymetric measure-
ments with the use of a spectrophotom-
eter - Unicam 5625 UV/VIS, USA. A 
calibration curve of the basic turbidity 
pattern was determined from five com-
parative suspensions: I, II, III, IV & V, 
representing the turbidity degrees of 
3, 6, 18, 30 and 45 NTU. An analytical 
wave length of λ = 400 nm of the light 
was adopted. The turbidity degree of the 
comparative suspensions was estimated 
by measuring the scattered light com-
pared to purified water as reference. A 
rectilinear plot was able to be drawn of 
the turbidity degree determined for the 
comparative suspensions. A maximal tur-
bidance of 0.171 was seen for compara-
tive suspension No. V. 
The aqueous extract is considered trans-
lucent if its translucence matches that of 
water measured at the same conditions or 
if its opalescence does not exceed that of 
comparative suspension No II, equal to 
6 NTU. 
Determination of heavy metal ions in 
the aqueous extracts
The content of heavy elements: cad-
mium, chromium (sum of all oxidation 
states), lead, zinc, and mercury in the 
aqueous extracts was determined by 
Atomic Absorption Spectroscopy using a 
SCAN-1 spectrometer made by Thermo 
Jawell ASH. Cadmium, chromium, lead 
and zinc were determined directly in the 
aqueous extracts by the flame method 
ASA (FAAS*) at the following param-
eters: 
n Cd: wave length λ = 228.8 nm, flame 
acetylene-air, limit of determination – 
0.02 mg/dm3 
n Cr: wave length λ = 357.9 nm, flame 
acetylene-N2O, limit of determination 
– 0.2 mg/dm3
and unmodified (code KO) implants were 
tested. 
Estimation of chemical purity
Parameters of the chemical purity were 
estimated based on results obtained in the 
risk analysis and on directives of Stand-
ards PN-EN ISO 10093-18:2009 and PN-
EN ISO 10993-1:2010.
Exhaustive extraction and three-step 
extraction
The content of leachable substances 
(profile of leachable substances) was 
estimated by the methods of exhaus-
tive and three-step extraction. The first 
was accomplished on Soxhlet apparatus 
with petroleum ether according to the 
procedure specified in Standard PN/P-
0607:1983. 
The three-step extraction was made 
in accordance with directives given in 
Standard EN ISO 10993-12:2009, where 
the following solvents were used in turn:
n purified water (water for injection by 
Baxter Co);
n 2-propanol according to the method 
given in Standard PN/P-04781/06;
n petroleum ether.
Extraction module: 10 g of test mate-
rial/100 cm3 of the extraction substance, 
based on guidelines contained in Stand-
ard PN-EN ISO 10993-12:2007 and in 
accordance with the 2009 revised edition 
of the Standard PN-EN ISO 10993-12 
(Table 1) . Standardised surface area and 
volume of extraction fluid for low-densi-
ty materials.
Preparation of aqueous extracts for 
estimation of chemical purity (analysis 
of the profile of leachable substances)
The aqueous extract was prepared with 
the following module: 10g of fine cut 
pieces of the material about 1 cm long 
on 100 cm3 of water for injection (Baxter 
Co) as per directives of Standard PN-EN 
ISO 10993-12:2009.
Steam sterilisation was made at 121oC 
for 60 minutes (p.10.3.1 of the stand-
ard; critical conditions for designed im-
plants). 
pH estimation in the aqueous extracts
The pH reaction of the aqueous extracts 
was measured in accordance with Stand-
ard PN-EN ISO 3071:2007 by a LAB 
860 SET pH-meter (Scott, Germany) 
equipped with a BluLine 14 pH electrode 
perature plasma (code KO), were fin-
ished the same way.
Prototypes of the knitted implants (both 
unmodified and modified by low temper-
ature plasma treatment) were packed in a 
double medical grade packaging system 
adaptable for steam sterilisation (OPM/
Poland) as described in [18] according to 
Standard [23].
Altogether 130 pieces of KO and PF im-
plants were prepared as a prototype batch 
for testing of accelerated ageing. Sam-
ples for testing were taken statistically 
from the whole knitwear batch, prepared 
on a semi-industrial scale and resembling 
typical industrial production. 
n Methods
Accelerated ageing 
The testing of accelerated ageing was 
designed on the basis of Standard ASTM 
F1980:2002: Standard Guide for Accel-
erated Ageing of Sterile Barrier Systems 
for Medical Devices. This document 
specifies guidelines for the accelerated 
ageing testing of medical packaging. 
However, it can be easily adapted to the 
accelerated ageing of medical devices 
(considering similar potential hazards) to 
assess the influence of storage conditions 
upon functional properties and the safety 
of newly designed medical devices. The 
medical devices designed placed in typi-
cal packaging (direct packaging satisfy-
ing quality requirements of Standards 
PN-EN ISO 11607-1:2011 and PN-EN 
868-5:2009) were tested after steam steri-
lisation in validated industrial conditions. 
The accelerated ageing was performed 
in a KBF 240 chamber (Binder GmbH/
Germany), where the elevated tempera-
ture was the factor simulating accelerated 
ageing. The temperature of the chamber 
was 60 ± 2 ºC and the RH 20 ± 5%, un-
der which conditions the medical devices 
were kept for 28 days (simulation of 1 
year of ageing) and 56 days (simulation 
of 2 year’s ageing).
The residence time of the medical de-
vices in the chamber was calculated us-
ing the Arrhenius equation (ASTM F 
1980:2002, p. 7.3.), adopting the value of 
3.7 as the ageing factor. The testing was 
performed at the accredited Laboratory 
of Metrology of the Institute of Security 
Technologies “MORATEX”, Lodz, Po-
land. Both plasma-modified (code PF) 
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n Pb: wave length λ = 217.0 nm, flame 
acetylene-air, limit of determination – 
0.2 mg/dm3
n Zn: wave length λ = 213.9 nm, flame 
acetylene-air, limit of determination – 
0.01 mg/dm3.
Mercury was determined by the method 
of cold vapour generation ASA (CVAAS) 
using a device for the generation of 
cold vapours - Atomic Vapor Accessory 
440, made by Thermo Jawell ASH, at 
the following parameters: wave length 
λ = 253.7 nm, reductive solution 5% 
SnCl2 in 20% HCl, carrier gas – Ar, and 
limit of determination – 0.01 mg/dm3. 
Determination of the permanganate 
value (oxidability) of the aqueous 
extracts
The permanganate value was determined 
according to the directives of Standard 
PN-P-04896:1984. Water for injection 
(Baxter Co) served as reference: it was 
subjected to the same processing condi-
tions as the sample tested. 
Determination of chloride ion content 
in the aqueous extracts
The content of chloride ions in the aque-
ous extracts was determined by the vis-
ual method described in Standard PN-P-
04895:1984. 
The method employs argentometry ti-
tration of the aqueous extracts prepared 
with a 0.01 mol/dm3 AgNO3 solution in 
the presence of chromium ions. The de-
termination limit of the method is 0.003 
mg of [Cl]–  ions /1g of the material 
tested. A 3.0% hydrogen peroxide solu-
tion was added at the end of titration to 
enhance the hue intensity at the colour 
change point. 
[Cl]– free injection water (Baxter Co.) 
was used to prepare the reference and 
solutions needed for the determination 
of chloride ions i.e. solutions of potas-
sium chromate, hydrogen peroxide and 
a standard volume solution of silver ni-
trate.
n Results and discussion
For the textile implants designed for use 
in urogynaecology and general surgery, 
results are presented of the examination 
of selected physical-chemical quality 
parameters which directly affect the op-
erational safety, especially when it comes 
to biocompatibility. Results of the param-
eter testing are compared with reference 
standards (KO and PF) of prototypes 
taken directly from the manufacturing 
process, which permitted to estimate the 
changes in chemical purity of the prod-
ucts proceeding in the course of ageing. 
pH of the aqueous extracts
Figure 1 presents pH values of aqueous 
extracts prepared from KO and PF im-
plants after 1 and 2 years of accelerated 
ageing compared with the reference. 
The pH values estimated for the starting 
prototype implants designed for hernia 
and vagina repair, both modified with 
low-temperature plasma and unmodified, 
amount to 6.2 (KO) and 6.3 (PF). pH val-
ues of aqueous extracts of the prototype 
medical devices, both modified and un-
modified, after 1 and 2 years of acceler-
ated ageing do not differ much from the 
starting value (reference); the value of 
pH is close to a neutral reaction and to 
that of human skin, actually falling into 
the optimal range for that type of medi-
cal device. 
The results confirm the absence of sub-
stances that could affect the change in 
pH reaction by migration after long stor-
age of the medical devices. It must be 
stressed that a pH below 4 and above 8 
brings about the risk of irritation of the 
surrounding tissue, which in extreme 
cases could be the reason for implant 
rejection or cause the forming of a thick 
cartilage capsule, leading to a stiffening 
of the implant locality 
Turbidity of the aqueous extracts
Figure 2 presents changes in the turbid-
ity of aqueous extracts prepared from the 
test implants proceeding in the course of 
accelerated ageing. 
Figure 2. Change in turbidity degree in aqueous extracts prepared from reference samples 
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Figure 1. Values of pH of aqueous extracts prepared from reference samples and from pro-
totype knitted implants KO and PF subjected to ageing simulated by acceleration. Limits of 











KO reference          KO after 1 year   KO after 2 years PF reference      PF after 1 year         PF after 2 year                
of ageing              of ageing of ageing             of ageing                 of ageing
6.2
6.5 6.5 6.56.3 6.4
137FIBRES & TEXTILES in Eastern Europe  2014, Vol. 22,  3(105)
The permissible safety level of the tur-
bidity of the aqueous extracts is marked 
in the graph (as laid down in Polish Phar-
macopoeiaVII).
The turbidity of aqueous extracts pre-
pared from the knitted implants did not 
remarkably change during accelerated 
ageing in comparison with the starting 
material, and its value did not exceed the 
limit of 3.
According to Polish Pharmacopoeia VII, 
recommendation for medical devices, a 
solution is considered transparent if the 
turbidity does not exceed the value of 
6 NTU. In view of the results presented 
above, it may be concluded that in the 
course of accelerated ageing no changes 
occur in the PP polymer which would 
promote the delivery of dulling substanc-
es to an extent hazardous to operational 
safety. The low-temperature plasma 
treatment slightly reduced the turbidity 
of the aqueous extract as result of the 
pretreatment of the fibre surface prior to 
the modification [18, 23].
Content of [Cl]- ions in the aqueous 
extracts
Chloride ions are one of the most serious 
impurities imparted to textile medical 
devices during manufacture, for example 
by the addition of auxiliary agents in the 
textile processing or remaining after the 
polymer synthesis. The substances tend 
to degrade in the product. Monitoring of 
the amount of [Cl]- ions migrating dur-
ing storage is crucial for the safety of the 
medical devices and also permits to as-
sess the potential risk of the delivery of 
chloride derivatives from the implanted 
device. 
The change in chloride ion content in 
aqueous extracts of the starting material 
and implants designed, KO and PF, after 
1 and 2 years of accelerated ageing is 
presented in Figure 3. 
Reductive substances in the aqueous 
extracts
Determination of the permanganate value 
of aqueous extracts from the medical de-
vices provides the possibility of assess-
ing the susceptibility of the polymeric 
material tested to oxidation processes 
proceeding in the course of accelerated 
ageing. A high content of reductive sub-
stances in the implant may bring about a 
risk of local reactivity after implantation. 
Materials inert both in respect of chemis-
try and biology are sought in the design-
ing of medical devices. An increase in 
the chemical reactivity of the implanted 
material promotes undesired biological 
processes which negatively affect the 
material itself by deteriorating its resist-
ance to corrosion and cause local post-
implantation effects. 
Figure 4 presents the change in the re-
ductive substance value (determined as 
permanganate oxidability) in aqueous ex-
tracts from prototype implants proceed-
ing during accelerated ageing. 
The permissible safety level of the per-
manganate value is marked in the graph. 
The permanganate value of aqueous ex-
tracts from the materials tested increased 
slightly for samples after 2 years of accel-
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Figure 3. Change in chloride ion content in aqueous extracts from the reference samples 
and prototype implants KO and PF subjected to simulated accelerated ageing. The permis-
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Figure 4. Change in permanganate value of aqueous extracts from reference samples and 
prototype implants KO and PF subjected to accelerated ageing. 
Table 1. Heavy metal content in aqueous extracts from the reference samples and prototype 
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< 0.02 < 0.02
Cr < 0.1 < 0.1
Pb < 0.2 < 0.2
Zn 0.025 0.043 0.029 0.039 0.022 0.019
Hg < 0.002 < 0.002
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fairly below the level regarded as safe in 
medical devices i.e. < 0.1 mg O2/g.
Content of heavy metal ions in the 
aqueous extracts
In Table 1 a quantitative profile is shown 
of the heavy metal content in aqueous 
extracts from the reference samples and 
prototype implants KO and PF before 
and after accelerated ageing.
In all of the samples of the prototype tex-
tile implants tested, the level of heavy 
metal content determined: Cd, Pb, Cr & 
Hg was below the limit of detection of 
the analytical method applied. The Zn 
content falls below the maximum permis-
sible value both in the starting material 
and prototype textile implants subjected 
to accelerated ageing. The last parameter 
slightly declined in the course of acceler-
ated ageing, which probably results from 
the fluctuating zinc content in the charge 
of the prototype knitted implants than 
from the ageing process itself. 
Exhaustive extraction
Three solvents were used in the exhaus-
tive extraction process: petroleum ether, 
2-propanol and water. Changes proceed-
ing in the amount of substances leachable 
in petroleum ether, 2-propanol and water 
for the reference samples and implants 
prototypes before and after the acceler-
ated ageing are presented in Table 2. 
Testing to determine the amount of leach-
able substances was twice repeated. 
In the accelerated ageing process an 
increased amount of petroleum ether-
leachable substance could be observed 
extracted from the prototypes of textile 
PF products (1st extraction step).
In comparison to the initial sample, an in-
crease of about 21% on average in the pe-
troleum ether-leachable substance from 
the PF material was noted after acceler-
ated ageing in conditions corresponding 
to 1 year of storage in real time. After 
the second extraction step, the amount of 
substance leached increased by 12% on 
average compared to the starting sample.
In the implants unmodified with low-
temperature plasma, the change tenden-
cy was similar, although the amount of 
leached substance was higher. 
After 2-year’s accelerated ageing, the 
content of petroleum ether-leachable 
substance increased in the first step by 
about 66% on average compared to the 
initial sample and by 7% on average af-
ter the second step. The parameter value 
increased in total by 48% on average 
compared to the initial sample. A similar 
tendency appeared in the unmodified im-
plants KO. However, the amount of leach-
able substances was distinctly higher. 
A similar phenomenon was observed in 
the consecutive extraction steps made 
with isopropanol and water. The results 
confirm a higher chemical purity of 
knitted PF implants modified by low-
temperature plasma treatment and their 
higher resistance to external factors in 
the course of accelerated ageing. 
The pretreatment of fibre in the process 
of fibre surface modification by low-tem-
perature plasma in the presence of low-
molecular fluoroorganic compounds [18, 
23] positively affects the chemical purity 
of the final medical device.
It ensues from literature [20] and Pol-
ish Pharmacopeia that the permissible 
amount of the substance leachable to the 
organic phase must not exceed 2 wt%. 
The quantitative composition of the ex-
tract is also important with respect to the 
substance posing a toxicity hazard. Since 
identification of the quantitative compo-
sition is difficult, the examination of bio-
compatibility according to Standard PN-
EN ISO 10993-1 appears crucial for safe 
use of the devices. It ultimately verifies 
and documents the chemical and biologi-
cal safety of prototypes of the medical 
devices designed. 
n Conclusions
The investigation in the accelerated age-
ing of ultra-light PP implants subjected 
to low-temperature plasma treatment 
with potential use in urogynecology and 
general surgery in the aspect of chemical 
purity constitutes a basis for determina-
tion of the effectiveness of the purify-
ing process (pretreatment of accelerated 
ageing ), the impact of the process upon 
the stability of chemical parameters and 
for defining changes proceeding in the 
course of storage in relation to real time. 
It was found that the profiles of leachable 
substances for the KO and PF do not dif-
fer substantially, with values indicating 
high chemical purity.
The differences in chemical purity pa-
rameters, particularly those in exhaustive 
extraction, may be ascribed to the pre-
treatment made in the low-temperature 
plasma modification of the textile im-
plant’s surface.
Assessment of chemical purity param-
eters of the medical devices has an im-
portant function in the relating of the 
profile of leachable substances to the ef-
fects of the biocompatibility examination 
both in a local and systemic aspect. This 
will be assessed in future investigations 
devoted to biocompatibility according 
to directives of Standard PN-EN ISO 
10993-1:2010 and in the examination of 
the impact of storage conditions upon the 
profile of the chemical purity of selected 
textile implants. 
The results of the present research indi-
cate that in the assessment of the profile 
of a leachable substance, advantage can 
be taken of some aspects of the chemical 
purity of textile medical devices, which 
Table 2. Changes proceeding in the amount of substances leachable in petroleum ether, isopropanol and water for the reference samples 
and implants prototypes before and after accelerated ageing.
Symbol of sample
Content of leachable substance, %
Extraction with petroleum ether Extraction with 2-propanol Extraction with H2O
Time of extraction, h
2 1 1.5 1.5 0.5
KO reference 0.408 0.330 0.121 0.129 0.009 < 0.001 <0.001 < 0.001 0.140 0.118
KO after 1 year of egeing 0.466 0.427 1.769 0.103 5.65 0.051 3.37 1.58 0.480 0.507
KO after 2 years of ageing 0.583 0.645 0.120 0.112 3.40 3.35 0.45 0.361 0.394 0.410
PF reference 0.276 0.358 0.132 0.174 < 0.001 0.038 < 0.001 < 0.001 0.087 0.077
PF after 1 year of egeing 0.392 0.420 0.092 0.095 0.154 0.174 0.077 0.091 0.102 0.090
PF after 2 years of ageing 0.463 0.439 0.222 0.216 1.46 1.54 0.275 0.183 0.479 0.520
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may differ depending upon the implant 
composition, its structure and processing, 
and the nature and time of contact with a 
human organism. Another aspect is also 
the assessment of the structural and topo-
graphic properties of the medical devices 
designed, permitting complex estimation 
of the impact of the said parameters upon 
the biological response to the textile de-
vice implanted. 
n Summary and conclusions
The research was aimed to:
1. estimate the impact of simulated stor-
age conditions on chemical purity of 
tested polypropylene implant materi-
als 
2. assess the risk which quality impaired 
by long storage may bear upon useful 
properties of the implant materials.
Assessment of the storage conditions 
in real time is, for obvious reasons, not 
acceptable, which is why simulated ac-
celerated storage was adopted, with el-
evated temperature playing the role of 
the time-accelerating factor according 
to the Arrhenius equation, which relates 
temperature with the reaction rate. 28 and 
56 days were adopted as equivalents of 
1 and 2 years of storage time. 
Chemical purity represented by pH, 
the turbidity of extracts, the contents of 
chloride anions, the reductive substance 
(oxidability) and heavy metals, and the 
amount of leachable substance was test-
ed for the freshly prepared materials and 
after the two (28 and 56 days) simulated 
periods.
The results are positive and encouraging. 
Most of the quality parameters did not 
change remarkably even after the 2-year 
period simulated. Practically all the qual-
ity indices remained in the permissible 
limit, giving proof that the storage time 
in terms of chemical purity does not pose 
a high risk for the PP implants tested. 
An undesired increase in the leachable 
substance was noted in a few test results, 
although the majority remained positive. 
In the last analysis, the plasma- treated 
material, denoted as PF, proved to be a 
much better material, with low leached 
amounts of the substance. It may be 
concluded that the PF material carries a 
much lower risk than the untreated PP 
device.
All the results are comparable with test 
results after 1 and 2 years of real time 
storage. 
The test results obtained indicate accept-
able chemical purity and predict a low 
risk in clinical practice of the devices 
tested, the PF material in particular. 
Assessment of chemical purity param-
eters of the medical devices has an im-
portant function in the relating of the 
profile of leachable substances to the ef-
fects of the biocompatibility examination 
both in a local and systemic aspect. Bio-
compatibility will be assessed in future 
investigations according to directives of 
Standard PN-EN ISO 10993-1:2010. It 
will provide final confirmation for surgi-
cal practice with a final assessment of the 
related risk of use after long storage. 
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